T42.0X5
Adverse effect of hydantoin derivatives
Clinical Classification Guidelines
Medical Intelligence & Overview
Hydantoin derivatives are a class of medications primarily used to control seizures in individuals with epilepsy. While these drugs can be effective in managing neurological conditions, they may also cause adverse effects in some patients. The ICD-10 code T42.0X5 specifically denotes an adverse effect related to hydantoin derivatives, highlighting the importance of monitoring and managing potential side effects to ensure safety and well-being.
Causes & Symptoms
Clinical Causes: Use of hydantoin derivative medications such as phenytoin, ethotoin, or fosphenytoin Individual sensitivity or hypersensitivity to the medication Incorrect dosage or prolonged use beyond recommended limits Drug interactions that increase the risk of adverse effects Pre-existing liver or kidney conditions affecting drug metabolism
Key Symptoms: Gingival hyperplasia (gum overgrowth) Nystagmus (involuntary eye movements) Diplopia (double vision) Rashes or allergic skin reactions Dizziness or ataxia (lack of muscle coordination) Cognitive disturbances such as confusion or drowsiness Hepatotoxicity signs like jaundice, fatigue, and abdominal pain Hematological effects such as leukopenia, thrombocytopenia, or aplastic anemia Lymphadenopathy (swollen lymph nodes)
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive review of the patient's medication history, clinical evaluation, and laboratory tests. Blood tests are often performed to monitor drug levels and assess liver function, blood counts, and kidney function. Electromyography or neurological assessments may be conducted if neurological symptoms are prominent. Adverse effects are typically identified by correlating symptoms with medication intake and ruling out other causes.
Treatment Protocols: Discontinuation or dosage adjustment of the offending hydantoin derivative under medical supervision Supportive care tailored to specific symptoms, such as topical treatments for skin reactions or medications for neurological symptoms Regular blood monitoring to detect hematologic or hepatic complications Switching to alternative antiepileptic medications if adverse effects persist Patient education on recognizing early signs of adverse reactions and when to seek medical attention
Clinical Advice & FAQs
Billing Guidance
Is T42.0X5 a billable ICD-10 code?
Yes, T42.0X5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T42.0X5?
Clinical documentation must specify the nature of Adverse effect of hydantoin derivatives and any associated comorbidities for accurate reporting.
Cite this Clinical Reference